arsenic has been researched along with Protein Aggregation, Pathological in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogra, Y; Quiroz, W; Verdugo, M | 1 |
| Alizadeh-Ghodsi, M; Ebrahimi-Kalan, A; Shiri-Shahsavar, MR; Yousefi, B; Zavvari, A | 1 |
2 other study(ies) available for arsenic and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Mechanisms underlying the toxic effects of antimony species in human embryonic kidney cells (HEK-293) and their comparison with arsenic species.
Topics: Antimony; Arsenicals; Cell Survival; Diffusion; Dose-Response Relationship, Drug; Fluorescence Recovery After Photobleaching; HEK293 Cells; Humans; Kinetics; Mitochondria; Oxidative Stress; Oxides; Protein Aggregates; Protein Aggregation, Pathological; Reactive Oxygen Species; Transfection | 2016 |
The hypothetical roles of arsenic in multiple sclerosis by induction of inflammation and aggregation of tau protein: A commentary.
Topics: Animals; Apoptosis; Arsenic; Brain; Cell Line; Disease Progression; Humans; Inflammation; Lipid Peroxidation; Malondialdehyde; Microtubules; Multiple Sclerosis; Neurons; Phosphorylation; Protein Aggregation, Pathological; tau Proteins | 2018 |